SCHEMBL26458952

SCHEMBL26458952

CC(C)(C)Cc1ccc2nc3c4ccccc4c4ccccc4n3c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.41
ALDH1A1 P00352 8/20 0.41
MAPT P10636 7/20 0.41
HPGD P15428 6/20 0.41
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
LMNA P02545 3/20 0.40
POLB P06746 3/20 0.40
HSD17B10 Q99714 3/20 0.40
TP53 P04637 2/20 0.40
TSHR P16473 3/20 0.37
GAA P10253 4/20 0.36
PKM P14618 1/20 0.36
USP2 O75604 2/20 0.35
CASP1 P29466 2/20 0.35
CASP7 P55210 2/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
HIF1A Q16665 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL861753 0.94 KDM4E (0.37) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL19743170 0.85 KDM4E (0.50) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL19928794 0.81 KDM4E (0.40) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL19735270 0.80 KDM4E (0.43) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL15428293 0.78 KDM4E (0.32) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL12759579 0.77 KDM4E (0.50) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL22113792 0.77 PTGER4 (0.38) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL18069027 0.76 KDM4E (0.56) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL37035230 0.75 KDM4E (0.61) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL10346630 0.75 KDM4E (0.61) KDM4EALDH1A1MAPTHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11641778-B2 Compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11641778-B2 Compound and organic light emitting device comprising same CRY1, CYP1A1, CRY2 KDM4E 2728/4885ALDH1A1 9/4885MAPT 1032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.